Clyra Medical of BioLargo Partners with Advanced Solution

Written by Emily J. Thompson, Senior Investment Analyst

Updated: Nov 13 2025

0mins

Distribution Agreement: BioLargo's subsidiary Clyra Medical Technologies has signed an exclusive stocking distribution agreement with Advanced Solution to promote and distribute ViaCLYR, a wound irrigation solution, across the U.S.
Clyrasept Technology: ViaCLYR utilizes Clyra's proprietary Clyrasept technology, which is a copper-iodine complex effective against a wide range of infection-causing organisms and has been FDA-cleared for safety and efficacy.
Collaboration Benefits: The partnership combines Clyra's innovative wound care technology with Advanced Solution's distribution network and clinical training expertise, aiming to enhance the adoption of ViaCLYR nationwide.
Market Launch Timeline: ViaCLYR is expected to be launched in the market in early 2026.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.